CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common stock
- Shares outstanding
- 15,075,924
- Total 13F shares
- 2,761,293
- Share change
- -190,594
- Total reported value
- $8,972,896
- Put/Call ratio
- 39%
- Price per share
- $3.25
- Number of holders
- 28
- Value change
- -$695,036
- Number of buys
- 11
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 230770109:
Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| A. J. Kazimi |
3/4/5
13D/G
|
Chairman and CEO, Director, 10%+ Owner |
38%
from 13D/G
|
6,263,310
mixed-class rows
|
$27,934,548 | +$3,173 | 18 Mar 2026 | |
| Ikarian Capital, LLC |
13D/G
13F
|
Company |
4.9%
|
730,932
|
$3,545,020 | $0 | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.1%
|
472,163
|
$1,879,209 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.7%
|
411,786
|
$1,638,909 | — | 31 Dec 2025 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
— |
4%
|
598,634
|
$1,618,467 | -$571,171 | 30 Sep 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.3%
|
341,087
|
$1,357,526 | — | 31 Dec 2025 | |
| Kenneth Krogulski |
3/4/5
|
Director |
2%
|
302,338
|
$1,354,474 | +$16,802 | 18 Mar 2026 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.8%
|
272,278
|
$1,083,667 | — | 31 Dec 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
163,468
|
$650,603 | — | 31 Dec 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.85%
|
128,507
|
$511,458 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
107,274
|
$427,005 | — | 31 Dec 2025 | |
| J. Goldman & Co LP |
13F
|
Company |
0.63%
|
94,541
|
$376,273 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.48%
|
72,513
|
$288,602 | — | 31 Dec 2025 | |
| Joseph C. Galante |
3/4/5
|
Director |
0.42%
|
63,656
|
$285,178 | — | 18 Mar 2026 | |
| Martin E. Cearnal |
3/4/5
|
Sr VP/Chief Commercial Officer, Director |
—
class O/S missing
|
163,473
|
$277,904 | — | 17 Mar 2022 | |
| Leo Pavliv |
3/4/5
|
SVP and Chief Development Off. |
—
class O/S missing
|
129,618
|
$220,351 | — | 31 May 2022 | |
| James Jones |
3/4/5
|
Director |
0.31%
|
46,863
|
$209,946 | +$3,173 | 18 Mar 2026 | |
| BlackRock, Inc. |
13F
|
Company |
0.35%
|
52,577
|
$209,256 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.32%
|
48,137
|
$191,586 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.29%
|
44,288
|
$176,000 | — | 31 Dec 2025 | |
| Joey A. Jacobs |
3/4/5
|
Director |
—
class O/S missing
|
98,415
|
$167,306 | — | 14 Jan 2023 | |
| Caroline Young |
3/4/5
|
Director |
0.23%
|
35,109
|
$157,288 | +$1,548 | 18 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
0.22%
|
33,700
|
$134,126 | — | 31 Dec 2025 | |
| Heron Bay Capital Management |
13F
|
Company |
0.19%
|
29,189
|
$116,172 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.17%
|
26,038
|
$103,631 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.16%
|
24,485
|
$97,450 | — | 31 Dec 2025 | |
| James L. Herman |
3/4/5
|
VP and Chief Compliance Office |
—
class O/S missing
|
21,000
|
$95,645 | — | 18 Mar 2026 | |
| Todd M. Anthony |
3/4/5
|
Vice Pres Organizational Dev |
—
class O/S missing
|
21,000
|
$93,060 | — | 18 Mar 2026 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.15%
|
21,957
|
$87,389 | — | 31 Dec 2025 | |
| Bitterman Chris T. |
3/4/5
|
Vice Pres Sales & Marketing |
—
class O/S missing
|
19,000
|
$82,720 | — | 18 Mar 2026 | |
| John M. Hamm |
3/4/5
|
VP Chief Financial Officer |
—
class O/S missing
|
18,250
|
$78,843 | — | 18 Mar 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
19,603
|
$78,020 | — | 31 Dec 2025 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0.12%
|
17,475
|
$69,551 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.1%
|
15,386
|
$61,237 | — | 31 Dec 2025 | |
| Martin S. Brown Jr. |
3/4/5
|
Director |
0.07%
|
10,300
|
$46,144 | — | 18 Mar 2026 | |
| Jonathan Griggs |
3/4/5
|
Director |
—
class O/S missing
|
14,803
|
$25,165 | — | 17 Mar 2021 | |
| Michael Bonner |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
11,720
|
$19,924 | — | 17 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
3,260
|
$12,975 | — | 31 Dec 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.01%
|
1,203
|
$4,787 | — | 31 Dec 2025 | |
| Capital Advisors, Ltd. LLC |
13F
|
Company |
0%
|
437
|
$2,000 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
200
|
$796 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
9
|
$36 | — | 31 Dec 2025 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
0%
|
1
|
$4 | — | 31 Dec 2025 |
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q1 2026
As of 31 Mar 2026,
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,761,293 shares.
The largest 10 holders included
Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD CAPITAL MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, PERCEPTIVE ADVISORS LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, J. Goldman & Co LP, and Bank of New York Mellon Corp.
This page lists
28
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
27
Q1 2026 holders
28
Holder diff
1
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.